ABIFLOX EFFICACY IN COMPLEX THERAPY OF PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
The article presents the results of the study, during which the efficacy of levofloxacin in the treatment of patients with community-acquired pneumonia was evaluated. It was found that levofloxacin is a highly effective treatment for patients with community-acquired pneumonia.
Main Authors: | T. I. Lyadova, О. V. Volobuyeva, Т. V. Sevastyanova, А. N. Savvo |
---|---|
Format: | Article |
Language: | English |
Published: |
V. N. Karazin Kharkiv National University
2013-12-01
|
Series: | Journal of V. N. Karazin Kharkiv National University: Series Medicine |
Online Access: | http://periodicals.karazin.ua/medicine/article/view/3409/2982 |
Similar Items
-
MODERN DIRECTIONS OF HERPESVIRUS INFECTIONS PHARMACOTHERAPY
by: T. I. Lyadova, et al.
Published: (2013-12-01) -
Current and future etiologic therapy of bacterial pneumonia. 1. Antibiotic therapy for community-acquired pneumonia
by: А.Е. Abaturov, et al.
Published: (2017-04-01) -
Individualization of antibacterial therapy in severe community acquired pneumonia considering systemic inflammation and immune status
by: Pertseva Т.О., et al.
Published: (2013-06-01) -
POSSIBILITIES OF USE OF IMMUNE MODULATORS IN COMPLEX THERAPY OF COMMUNITY-ACQUIRED PNEUMONIAS
by: E. S. Korovkina, et al.
Published: (2017-08-01) -
Community-acquired pneumonia in HIV patients
by: I. B. Viktorova, et al.
Published: (2021-05-01)